Detalhe da pesquisa
1.
CD95L concatemers highlight different stoichiometries of CD95-mediated apoptotic and nonapoptotic pathways.
Eur J Immunol
; 54(1): e2350626, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37837385
2.
Early detection of pancreatic cancer by liquid biopsy "PANLIPSY": a french nation-wide study project.
BMC Cancer
; 24(1): 709, 2024 Jun 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38853244
3.
Effect of Novel AKT Inhibitor Vevorisertib as Single Agent and in Combination with Sorafenib on Hepatocellular Carcinoma in a Cirrhotic Rat Model.
Int J Mol Sci
; 23(24)2022 Dec 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36555845
4.
Mechanobiology and survival strategies of circulating tumor cells: a process towards the invasive and metastatic phenotype.
Front Cell Dev Biol
; 11: 1188499, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37215087
5.
In vitro cross-talk between metastasis-competent circulating tumor cells and platelets in colon cancer: a malicious association during the harsh journey in the blood.
Front Cell Dev Biol
; 11: 1209846, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37601099
6.
First evidence of AXL expression on circulating tumor cells in metastatic breast cancer patients: A proof-of-concept study.
Cancer Med
; 2023 Dec 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38132919
7.
Chronic Intermittent Hypoxia Increases Cell Proliferation in Hepatocellular Carcinoma.
Cells
; 11(13)2022 06 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35805134
8.
MMP7 cleavage of amino-terminal CD95 death receptor switches signaling toward non-apoptotic pathways.
Cell Death Dis
; 13(10): 895, 2022 10 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36274061
9.
Soluble CD95L in cancers and chronic inflammatory disorders, a new therapeutic target?
Biochim Biophys Acta Rev Cancer
; 1876(2): 188596, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34324950
10.
DEN-Induced Rat Model Reproduces Key Features of Human Hepatocellular Carcinoma.
Cancers (Basel)
; 13(19)2021 Oct 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34638465
11.
GNS561 acts as a potent anti-fibrotic and pro-fibrolytic agent in liver fibrosis through TGF-ß1 inhibition.
Ther Adv Chronic Dis
; 11: 2040622320942042, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32728410
12.
Animal Models of Hepatocellular Carcinoma: The Role of Immune System and Tumor Microenvironment.
Cancers (Basel)
; 11(10)2019 Oct 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31581753
13.
Immunologic Features of Patients With Advanced Hepatocellular Carcinoma Before and During Sorafenib or Anti-programmed Death-1/Programmed Death-L1 Treatment.
Clin Transl Gastroenterol
; 10(7): e00058, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31295151
14.
Combination of AKT inhibitor ARQ 092 and sorafenib potentiates inhibition of tumor progression in cirrhotic rat model of hepatocellular carcinoma.
Oncotarget
; 9(13): 11145-11158, 2018 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-29541403
15.
Efficacy of AKT Inhibitor ARQ 092 Compared with Sorafenib in a Cirrhotic Rat Model with Hepatocellular Carcinoma.
Mol Cancer Ther
; 16(10): 2157-2165, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28566435